Evaluation of Efficacy and Safety of Ayurveda Intervention (Ayush -64) in the management of COVID-19 infection (Asymptomatic &Mild to Moderate symptoms)- An open label single arm prospective clinical trial

Central Council For Research in Ayurvedic Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1.Asymptomatic, Mild to moderate cases registered in A & U, Tibia hospital above 18-60 years of age, with COVID 2019 (Confirmed by RT-PCR or Rapid Antigen Test) quarantined at identified hospital set up.
•2.Participants who can take medicines orally
•3.Patients willing to provide signed informed consent

•1.Cases of severe vomiting which would make oral administration of medicine difficult.
•2.Cases of respiratory failure and requiring mechanical ventilation.
•3.Alanine Transaminase (ALT) or Aspartate Transaminase (AST) > 2 times the upper limit of normal.
•4.Patients with COVID 19 in critical condition or ARDS or NIAD 8 â??point ordinal score 2 Hospitalized, on invasive mechanical Ventilation or extra corporeal membrane oxygenation
•5.Pregnant or lactating women
•6.Any other condition, which as per the investigator would jeopardize the outcome of the trial.

发起方